Related Experiment Video
Updated: May 29, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting?
Hiroaki Sakamoto1, Yasunori Watanabe, Masataka Satou
1Department of Cardiovascular Surgery, Hitachi General Hospital, Hitachi, Ibaraki, Japan. sakamotoh@md.tsukuba.ac.jp
Insights
Preoperative statin therapy significantly reduced the incidence of postoperative atrial fibrillation (AF) following coronary artery bypass grafting (CABG). This finding suggests statins may be beneficial in preventing AF after cardiac surgery.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Statins possess pleiotropic effects, including anti-inflammatory and potential atrial fibrillation (AF) preventive properties.
- Postoperative AF is a common complication after coronary artery bypass grafting (CABG).
Purpose of the Study:
- To evaluate the efficacy of preoperative statin therapy in mitigating the risk of AF subsequent to CABG.
- To identify predictors of AF development after CABG.
Main Methods:
- A retrospective analysis of 221 patients undergoing CABG between 2004 and 2007.
- Patients were stratified into preoperative statin (n=77) and non-statin (n=126) groups, and into postoperative AF (n=54) and non-AF (n=149) groups.
- Multivariate analysis was employed to determine independent predictors of postoperative AF.
Main Results:
- The overall incidence of postoperative AF was 26%.
- Patients receiving preoperative statin therapy exhibited a significantly lower incidence of postoperative AF (16%) compared to the non-statin group (33%, p=0.005).
- Independent predictors for AF development included preoperative statin use (OR 0.327, p=0.05) and age (OR 1.058, p=0.035).
Conclusions:
- Preoperative statin therapy appears to be an effective strategy for reducing the incidence of AF after CABG.
- Statin therapy may play a protective role against the development of atrial fibrillation in the post-cardiac surgery setting.
Objective:
Recent studies have demonstrated that statins have pleiotropic effects, including anti-inflammatory effects and atrial fibrillation (AF) preventive effects. The objective of this study was to assess the efficacy of preoperative statin therapy in preventing AF after coronary artery bypass grafting (CABG).
Methods:
221 patients underwent CABG in our hospital from 2004 to 2007. 14 patients with preoperative AF and 4 patients with concomitant valve surgery were excluded from this study. Patients were divided into two groups to examine the influence of statins: those with preoperative statin therapy (Statin group, n = 77) and those without it (Non-statin group, n = 126). In addition, patients were divided into two groups to determine the independent predictors for postoperative AF: those with postoperative AF (AF group, n = 54) and those without it (Non-AF group, n = 149). Patient data were collected and analyzed retrospectively.
Results:
The overall incidence of postoperative AF was 26%. Postoperative AF was significantly lower in the Statin group compared with the Non-statin group (16% versus 33%, p = 0.005). Multivariate analysis demonstrated that independent predictors of AF development after CABG were preoperative statin therapy (odds ratio [OR] 0.327, 95% confidence interval [CI] 0.107 to 0.998, p = 0.05) and age (OR 1.058, 95% CI 1.004 to 1.116, p = 0.035).
Conclusion:
Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Angina IV: Management

